✦ LIBER ✦
Long-term follow-up confirms a survival advantage of the paclitaxel–cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer
✍ Scribed by M. J. Piccart; K. Bertelsen; G. Stuart; J. Cassidy; C. Mangioni; E. Simonsen; K. James; S. Kaye; I. Vergote; R. Blom; R. Grimshaw; R. Atkinson; K. Swenerton; C. Trope; M. Nardi; J. Kaern; S. Tumolo; P. Timmers; J.-A. Roy; F. Lhoas; B. Lidvall; M. Bacon; A. Birt; J. Andersen; B. Zee; J. Paul; S. Pecorelli; B. Baron; W. Mcguire
- Book ID
- 109085253
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 102 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1048-891X
No coin nor oath required. For personal study only.